The CRL Insurers Blog is Moving!Thank you for reading our blog posts here on Medium.com. As we continued to build our digital presence and showcase updates from our…Aug 10, 2021Aug 10, 2021
COVID-19 Long-Haul EffectsCRL Chief Scientific Officer Dr. Robert Stout discusses the lasting impact of COVID-19 infection in both symptomatic and asymptomatic…Aug 4, 2021Aug 4, 2021
Marijuana Use During the COVID-19 PandemicDr. Steven J. Rigatti explores marijuana use during the COVID-19 pandemic as a follow-up to earlier commentary on alcohol and tobacco use.Jul 8, 2021Jul 8, 2021
Recent Publications on Mortality: Impacts on InsurersRecently Dr. Michael Fulks commented on 2020 mortality data from JAMA, citing an increase of 17.7% from 2019 to 2020 (click here for the…Jun 28, 2021Jun 28, 2021
2020 US Mortality Results: How do they compare to prior years?Dr. Michael Fulks, Consulting Medical Director to CRL, comments on the 2020 leading causes of death in a COVID-19 world.Jun 17, 2021Jun 17, 2021
The Emerging Marijuana Challenge: Δ8-THCMarijuana testing is used by a number of life insurers in the risk assessment process. New chemical entities will make risk more difficult…May 18, 2021May 18, 2021
Urine Protein Tests: A Mortality Predictor in Life Insurance PopulationsUrine protein tests offer a simple way for insurance companies to obtain an important predictor of life risk. CRL recently completed an…Mar 31, 2021Mar 31, 2021
Bad Habits and the PandemicDr. Steven J. Rigatti, Consulting Medical Director to CRL, comments on alcohol and tobacco usage rates from a pre-pandemic period to a…Mar 10, 2021Mar 10, 2021
New CRL COVID-19 Research: Viral Load in Asymptomatic vs. Symptomatic Cases is SimilarA new paper on COVID-19 research from CRL doctors was published this week. Over 460k samples collected from July 2020 to January 2021 were…Feb 22, 2021Feb 22, 2021
